Lariboisière Cognitive Assessment: Evaluation of the 1-year Outcomes

计划入组 400 人 · 首次发布于 2023 年 12 月 14 日

Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière

计划入组 5,000 人 · 首次发布于 2023 年 9 月 7 日

Creation of a Biological Collection for Medical Research Purposes for Patients at the Reference Center for Rare Diseases of the Blood Vessels of the Brain and Eye at Lariboisière Hospital

计划入组 500 人 · 首次发布于 2025 年 12 月 4 日

CALRLong36 peptide(Herlev Hospital)

GSDMD siRNA(Ruijin Hospital)

TIL therapy(Herlev Hospital)

Hôpital Fribourgeois

Switzerland

Hôpital Montfort

Canada

Hôpital Erasme

Belgium

Orphalan Acquires Orphelia Pharma to Strengthen Rare Disease Portfolio in Pediatric Neurology and Oncology

Allo-SCT Demonstrates Long-Term Superiority Over Standard Care in Sickle Cell Anemia

Bulevirtide Monotherapy Shows Sustained Safety and Tolerability in Chronic Hepatitis Delta